The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients

Clinical and Experimental Medicine

Volumn 8, Issue 4, 2008, Pages 179-185

  Tsao, Jeng Ting ^a   Kuo, Chia Chen ^a   Lin, Shih Chang ^a,b,c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b Cathay Medical Center   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Cytokine inducible SH2 protein (CIS); Rheumatoid arthritis (RA); Suppressors of cytokine signaling (SOCS); Systemic lupus erythematosus (SLE)

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; METHOTREXATE; PROTEIN SH2; SALAZOSULFAPYRIDINE; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN; CYTOKINE INDUCIBLE SH2-CONTAINING PROTEIN; MESSENGER RNA; PRIMER DNA; SOCS1 PROTEIN, HUMAN; SOCS2 PROTEIN, HUMAN; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 61549104493     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-008-0006-0     Document Type: Article

References (45)

1. K Rakesh DK Agrawal 2005 Controlling cytokine signaling by constitutive inhibitors Biochem Pharmacol 70 649 657
2. M Fujimoto T Naka 2003 Regulation of cytokine signaling by SOCS family molecules Trends Immunol 24 659 666
3. WS Alexander DJ Hilton 2004 The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response Annu Rev Immunol 22 503 529
4. A Yoshimura T Naka M Kubo 2007 SOCS proteins, cytokine signalling and immune regulation Nat Rev Immunol 7 454 465
5. S Li S Chen X Xu 2000 Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells J Exp Med 191 985 994
6. A Matsumoto Y Seki M Kubo 1999 Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice Mol Cell Biol 19 6396 6407
7. T Naka T Matsumoto M Narazaki 1998 Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice Proc Natl Acad Sci USA 95 15577 15582
8. R Starr D Metcalf AG Elefanty 1998 Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1 Proc Natl Acad Sci USA 95 14395 14399
9. WS Alexander R Starr JE Fenner 1999 SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine Cell 98 597 608
10. J-C Marine DJ Topham C McKay 1999 SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality Cell 98 609 616
11. I Kinjyo T Hanada K Inagaki-Ohara 2002 SOCS1/JAB is a negative regulator of LPS-induced macrophage activation Immunity 17 583 591
12. R Nakagawa T Naka H Tsutsui 2002 SOCS-1 participates in negative regulation of LPS responses Immunity 17 677 687
13. T Hanada H Yoshida S Kato 2003 Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity Immunity 19 437 450
14. + T cells Nat Immunol 6 715 721
15. D Metcalf CJ Greenhalgh E Viney 2000 Gigantism in mice lacking suppressor of cytokine signalling-2 Nature 405 1069 1073
16. CJ Greenhalgh E Rico-Bautista M Lorentzon 2005 SOCS2 negatively regulates growth hormone action in vitro and in vivo J Clin Invest 115 397 406
17. E Rico-Bautista A Flores-Morales L Fernández-Pérez 2006 Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions Cytokine Growth Factor Rev 17 431 439
18. 4 and aspirin-triggered lipoxin are SOCS-2 dependent Nat Med 12 330 334
19. SJ Cohney D Sanden NA Cacalano 1999 SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation Mol Cell Biol 19 4980 4988
20. A Suzuki T Hanada K Mitsuyama 2001 CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation J Exp Med 193 471 481
21. H2-mediated allergic responses Nat Med 9 1047 1054
22. H Yasukawa M Ohishi H Mori 2003 IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages Nat Immunol 4 551 556
23. H Takatori H Nakajima S Kagami 2005 Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression J Immunol 174 4105 4112
24. Z Chen A Laurence Y Kanno 2006 Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells Proc Natl Acad Sci USA 103 8137 8142
25. high regulatory T cells Int Immunol 18 555 563
26. L Llorente Y Richaud-Patin C García-Padilla 2000 Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus Arthritis Rheum 43 1790 1800
27. M Feldmann R Maini 2001 Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19 163 196
28. BR Lauwerys FA Houssiau 2003 Involvement of cytokines in the pathogenesis of systemic lupus erythematosus Adv Exp Med Biol 520 237 251
29. P Miossec 2004 An update on the cytokine network in rheumatoid arthritis Curr Opin Rheumatol 16 218 222
30. J Banchereau V Pascual 2006 Type I interferon in systemic lupus erythematosus and other autoimmune diseases Immunity 25 383 392
31. EM Tan AS Cohen JF Fries 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271 1277
32. FC Arnett SM Edworthy DA Bloch 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324
33. C Bombardier D Gladman M Urowitz D Caron C Chang 1992 Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 35 630 640
34. M Fujimoto H Tsutsui O Xinshou 2004 Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases Int Immunol 16 303 314
35. L Llorente W Zou Y Levy 1995 Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J Exp Med 181 839 844
36. JK Lacki P Leszczynski J Kelemen W Müller SH Mackiewicz 1997 Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response J Med 28 99 107
37. X Shen F Hong VA Nguyen B Gao 2000 IL-10 attenuates IFN-α-activated STAT1 in the liver: involvement of SOCS2 and SOCS3 FEBS Lett 480 132 136
38. PJ Egan KE Lawlor WS Alexander IP Wicks 2003 Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation J Clin Invest 111 915 924
39. PK Wong PJ Egan 2006 Croker BA et al (2006) SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis J Clin Invest 116 1571 1581
40. T Shouda T Yoshida T Hanada 2001 Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J Clin Invest 108 1781 1788
41. J Shou CM Bull L Li 2006 Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model Arthritis Res Ther 8 R28
42. P Isomäki T Alanärä P Isohanni 2007 The expression of SOCS is altered in rheumatoid arthritis Rheumatology 46 1538 1546
43. PJ Charles RJT Smeenk J De Jong M Feldmann RN Maini 2000 Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: findings in open-label and randomized placebo-controlled trials Arthritis Rheum 43 2383 2390
44. N Shakoor M Michalska CA Harris JA Block 2002 Drug-induced systemic lupus erythematosus associated with etanercept therapy Lancet 359 645
45. M De Bandt J Sibilia X Le Loët 2005 Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey Arthritis Res Ther 7 R545 R551